These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3564408)

  • 21. [Bile acids and cholesterol in the bile in biliary tract diseases].
    Miroshnichenko VP; Gaĭdaĭ VN
    Vrach Delo; 1984 Jul; (7):27-9. PubMed ID: 6475014
    [No Abstract]   [Full Text] [Related]  

  • 22. [Certain biochemical indicators of bile composition in biliary tract diseases in children].
    Donde SM
    Pediatriia; 1975 Mar; (3):34-6. PubMed ID: 1118235
    [No Abstract]   [Full Text] [Related]  

  • 23. Origin of oxysterols in hepatic bile of patients with biliary infection.
    Yoshida T; Matsuzaki Y; Haigh WG; Fukushima S; Ikezawa K; Tanaka N; Lee SP
    Am J Gastroenterol; 2003 Oct; 98(10):2275-80. PubMed ID: 14572579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bile lipid complex in chronic gastritis and gastroduodenitis in combination with biliary tract diseases].
    Mokhun' IK; Luk'ianchuk DG; Shubravskiĭ AA
    Vrach Delo; 1978 Sep; (9):72-4. PubMed ID: 706329
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenetic significance of bile acid metabolism in the postcholecystectomy syndrome.
    Iwamura K
    Tokai J Exp Clin Med; 1980 Apr; 5(2):217-32. PubMed ID: 7414633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Trace element analysis of patients with biliary stones].
    Chen LY; Su RB
    Zhonghua Wai Ke Za Zhi; 1987 Jun; 25(6):343-5, 381. PubMed ID: 3691237
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: The influence of biliary disease on the excretion of cephazolin sodium in human bile.
    Strachan CJ; Crapp AR; Powis SJ; Wise R; Bevan P
    Br J Surg; 1976 Feb; 63(2):163. PubMed ID: 1252767
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of the cholate-cholesterol coefficient in bile].
    Gromashevskaia LL; Miroshnichenko VP; Naumenko VN; Kasatkina MG; Ivashchenko VM
    Sov Med; 1984; (3):23-6. PubMed ID: 6719233
    [No Abstract]   [Full Text] [Related]  

  • 29. [Method of fractionating free and conjugated bile biliary acids].
    Gromashevskaia LL; Neborachko VS; Kasatkina MG; Burka AA; Ivashchenko VM
    Lab Delo; 1979; (3):176-80. PubMed ID: 85769
    [No Abstract]   [Full Text] [Related]  

  • 30. [Causes of biliary sludge].
    Sil'verstova SIu; Il'chenko AA; Drozdov VN; Vikhrova TV; Orlova IuN
    Ter Arkh; 2003; 75(2):38-42. PubMed ID: 12685389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases.
    Körner T; Kropf J; Hackler R; Brenzel A; Gressner AM
    Hepatology; 1996 Mar; 23(3):423-8. PubMed ID: 8617420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The composition of human hepatic bile during the postoperative period].
    Szigeti A; Zajkás G; Tarján R; Mester E
    Orv Hetil; 1969 Feb; 110(7):373-4. PubMed ID: 5780288
    [No Abstract]   [Full Text] [Related]  

  • 33. The condition of the biliary tract and cholesecretion in cases of ulcerative colitis.
    Abasov IT; Isaev EG; Iof IM
    Hepatogastroenterology; 1985 Jun; 32(3):138-40. PubMed ID: 4018708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The characteristics of "white bile".
    Bouchier IA; Cooperband SR
    Gastroenterology; 1965 Oct; 49(4):354-9. PubMed ID: 5831778
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori and the risk of benign and malignant biliary tract disease.
    Bulajic M; Maisonneuve P; Schneider-Brachert W; Müller P; Reischl U; Stimec B; Lehn N; Lowenfels AB; Löhr M
    Cancer; 2002 Nov; 95(9):1946-53. PubMed ID: 12404289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the physicochemical and biochemical properties of bile in chronic diseases of the hepatobiliary system in the treatment process at health resorts].
    Guba NM; Vershinskaia NV; Guba MI
    Vrach Delo; 1981 Feb; (2):83-6. PubMed ID: 7222622
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of Salmonella enterica serovar typhi in bile and stool of patients with biliary diseases and those requiring biliary drainage for other purposes.
    Vaishnavi C; Singh S; Kochhar R; Bhasin D; Singh G; Singh K
    Jpn J Infect Dis; 2005 Dec; 58(6):363-5. PubMed ID: 16377868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Method for determination of bile volume with indocyanine green].
    Maurer C; Meier B
    Z Gastroenterol; 1971; 9(3):159-65. PubMed ID: 5164760
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the physicochemical properties and trace element content of bile in exacerbated chronic cholangiohepatitis].
    Pocheptsov VG; Khvorostinka VN; Kozarezenko PM; Glushak AP
    Vrach Delo; 1972 Feb; 2():4-7. PubMed ID: 5084741
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.